NO20072499L - Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser - Google Patents

Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser

Info

Publication number: NO20072499L
Authority: NO; Norway
Prior art keywords: methods; receptor binding; compositions; applications; melanocortin receptor
Prior art date: 2004-10-25

Application number

NO20072499A

Other languages

English (en)

Norwegian (no)

Inventor

Mark Cunningham

Vedrana Stojanovic-Susulic

Karyn O'neil

Chichi Huang

Jeffrey Luo

Original Assignee

Centocor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-25

Filing date

2007-05-15

Publication date

2007-07-16

2007-05-15 Application filed by Centocor Inc filed Critical Centocor Inc

2007-07-16 Publication of NO20072499L publication Critical patent/NO20072499L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Hematology (AREA)
Obesity (AREA)
Neurology (AREA)
Cell Biology (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Cardiology (AREA)
Biotechnology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20072499A 2004-10-25 2007-05-15 Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser NO20072499L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62196004P	2004-10-25	2004-10-25
PCT/US2005/038431 WO2006047535A2 (en)	2004-10-25	2005-10-25	Melanocortin receptor binding mimetibodies, compositions, methods and uses

Publications (1)

Publication Number	Publication Date
NO20072499L true NO20072499L (no)	2007-07-16

Family

ID=36228385

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20072499A NO20072499L (no)	2004-10-25	2007-05-15	Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser

Country Status (29)

Country	Link
US (1)	US20060105951A1 (pt)
EP (1)	EP1812046B1 (pt)
JP (1)	JP2008517605A (pt)
KR (1)	KR101255140B1 (pt)
CN (1)	CN101437540B (pt)
AT (1)	ATE501731T1 (pt)
AU (1)	AU2005299440B2 (pt)
BR (1)	BRPI0518411A2 (pt)
CA (1)	CA2585287A1 (pt)
CY (1)	CY1111486T1 (pt)
DE (1)	DE602005026970D1 (pt)
DK (1)	DK1812046T3 (pt)
EA (1)	EA200700944A1 (pt)
EC (1)	ECSP077416A (pt)
ES (1)	ES2363023T3 (pt)
HK (1)	HK1106445A1 (pt)
HR (1)	HRP20110405T1 (pt)
IL (1)	IL182683A0 (pt)
MA (1)	MA28943B1 (pt)
ME (1)	ME01234B (pt)
MX (1)	MX2007004974A (pt)
NO (1)	NO20072499L (pt)
PL (1)	PL1812046T3 (pt)
PT (1)	PT1812046E (pt)
RS (1)	RS51789B (pt)
SI (1)	SI1812046T1 (pt)
TN (1)	TNSN07157A1 (pt)
WO (1)	WO2006047535A2 (pt)
ZA (1)	ZA200704260B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7910101B2 (en) *	2004-10-25	2011-03-22	Centocor, Inc.	Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en)	2005-10-07	2010-09-07	Codman & Shurtleff, Inc.	Implantable pump for protein delivery for obesity control by drug infusion into the brain
CA2727317C (en)	2008-06-09	2015-02-17	Palatin Technologies, Inc.	Melanocortin receptor-specific peptides for treatment of sexual dysfunction
TW201002340A (en) *	2008-06-09	2010-01-16	Palatin Technologies Inc	Melanocortin receptor-specific peptides for treatment of obesity
US8614185B2 (en) *	2009-05-04	2013-12-24	Centocor Ortho Biotech Inc.	Fusion proteins of alpha-MSH derivatives and Fc
NZ596617A (en)	2009-06-08	2014-04-30	Palatin Technologies Inc	Melanocortin receptor-specific peptides
WO2010144341A2 (en)	2009-06-08	2010-12-16	Palatin Technologies, Inc.	Lactam-bridged melanocortin receptor-specific peptides
UY32690A (es)	2009-06-08	2011-01-31	Astrazeneca Ab	Péptidos específicos para receptores de melanocortina
MX2012005859A (es)	2009-11-23	2012-12-17	Palatin Technologies Inc	Peptidos lineales especificos del receptor de melanocortina-1.
MX2012005862A (es)	2009-11-23	2012-09-07	Palatin Technologies Inc	Peptidos ciclicos especificos del receptor de melanocortina-1.
JP2020141710A (ja) *	2011-07-06	2020-09-10	ゲンマブエー／エス	抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (zh) *	2019-03-02	2020-09-10	上海一宸医药科技有限公司	一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3117600A (en) *	1998-12-09	2000-06-26	Eleanor Roosevelt Institute	Composition and method for regulation of body weight and associated conditions
AU2001275930B2 (en) *	2000-07-14	2007-05-10	Eisai Inc.	Alpha-msh related compounds and methods of use
EP1545608A4 (en) *	2002-06-28	2006-09-13	Centocor Inc	CH1-DELETED MAMMED MUICETIC BODIES, COMPOSITIONS, METHODS AND APPLICATIONS
CA2490411A1 (en) *	2002-06-28	2004-01-08	Centocor, Inc.	Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
WO2005097175A2 (en) *	2004-03-31	2005-10-20	Centocor, Inc.	Human glp-1 mimetibodies, compositions, methods and uses

2005
- 2005-10-25 WO PCT/US2005/038431 patent/WO2006047535A2/en active Application Filing
- 2005-10-25 EP EP05819741A patent/EP1812046B1/en active Active
- 2005-10-25 ME MEP-2011-85A patent/ME01234B/me unknown
- 2005-10-25 ES ES05819741T patent/ES2363023T3/es active Active
- 2005-10-25 EA EA200700944A patent/EA200700944A1/ru unknown
- 2005-10-25 MX MX2007004974A patent/MX2007004974A/es unknown
- 2005-10-25 AT AT05819741T patent/ATE501731T1/de active
- 2005-10-25 BR BRPI0518411-8A patent/BRPI0518411A2/pt not_active IP Right Cessation
- 2005-10-25 PL PL05819741T patent/PL1812046T3/pl unknown
- 2005-10-25 DE DE602005026970T patent/DE602005026970D1/de active Active
- 2005-10-25 RS RS20110230A patent/RS51789B/en unknown
- 2005-10-25 CN CN2005800447902A patent/CN101437540B/zh not_active Expired - Fee Related
- 2005-10-25 JP JP2007538172A patent/JP2008517605A/ja active Pending
- 2005-10-25 PT PT05819741T patent/PT1812046E/pt unknown
- 2005-10-25 SI SI200531295T patent/SI1812046T1/sl unknown
- 2005-10-25 DK DK05819741.9T patent/DK1812046T3/da active
- 2005-10-25 AU AU2005299440A patent/AU2005299440B2/en not_active Ceased
- 2005-10-25 CA CA002585287A patent/CA2585287A1/en not_active Abandoned
- 2005-10-25 KR KR1020077011487A patent/KR101255140B1/ko not_active IP Right Cessation
- 2005-10-25 US US11/257,851 patent/US20060105951A1/en not_active Abandoned
2007
- 2007-04-19 IL IL182683A patent/IL182683A0/en unknown
- 2007-04-23 MA MA29843A patent/MA28943B1/fr unknown
- 2007-04-24 TN TNP2007000157A patent/TNSN07157A1/fr unknown
- 2007-04-25 EC EC2007007416A patent/ECSP077416A/es unknown
- 2007-05-15 NO NO20072499A patent/NO20072499L/no not_active Application Discontinuation
- 2007-05-24 ZA ZA200704260A patent/ZA200704260B/xx unknown
- 2007-11-05 HK HK07112011.3A patent/HK1106445A1/xx not_active IP Right Cessation
2011
- 2011-05-23 CY CY20111100502T patent/CY1111486T1/el unknown
- 2011-05-31 HR HR20110405T patent/HRP20110405T1/hr unknown

Also Published As

Publication number	Publication date
US20060105951A1 (en)	2006-05-18
EP1812046B1 (en)	2011-03-16
SI1812046T1 (sl)	2011-06-30
ES2363023T3 (es)	2011-07-19
KR20070085416A (ko)	2007-08-27
KR101255140B1 (ko)	2013-04-22
PT1812046E (pt)	2011-06-28
EA200700944A1 (ru)	2008-04-28
JP2008517605A (ja)	2008-05-29
RS51789B (en)	2011-12-31
ME01234B (me)	2013-06-20
ECSP077416A (es)	2007-05-30
EP1812046A4 (en)	2009-11-11
WO2006047535A2 (en)	2006-05-04
CN101437540A (zh)	2009-05-20
MA28943B1 (fr)	2007-10-01
BRPI0518411A2 (pt)	2008-11-18
CY1111486T1 (el)	2015-08-05
IL182683A0 (en)	2007-09-20
ZA200704260B (en)	2009-03-25
AU2005299440B2 (en)	2011-12-15
HK1106445A1 (en)	2008-03-14
ATE501731T1 (de)	2011-04-15
DE602005026970D1 (de)	2011-04-28
WO2006047535A3 (en)	2008-09-04
HRP20110405T1 (hr)	2011-06-30
CN101437540B (zh)	2012-12-19
PL1812046T3 (pl)	2011-08-31
MX2007004974A (es)	2007-10-17
EP1812046A2 (en)	2007-08-01
AU2005299440A1 (en)	2006-05-04
DK1812046T3 (da)	2011-06-06
CA2585287A1 (en)	2006-05-04
TNSN07157A1 (en)	2008-11-21

Publication	Publication Date	Title
NO20072499L (no)	2007-07-16	Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser
WO2007041635A3 (en)	2008-11-13	Fc variants with optimized fc receptor binding properties
TW200611910A (en)	2006-04-16	Interferon-alpha polypeptides and conjugates
MX2008000230A (es)	2008-04-07	Proteinas de enlace il-6.
WO2007079218A3 (en)	2008-07-10	Metalloproteinase binding proteins
DK2574640T3 (da)	2023-04-24	Bindemidler og dermed fremstillede materialer
WO2006017538A3 (en)	2007-05-18	Hk1-binding proteins
GB0700909D0 (en)	2007-02-28	Novel antigen-binding polypeptides and their uses
TW200720076A (en)	2007-06-01	Composite materials and methods of making the same
EA200702278A1 (ru)	2008-08-29	Антитела, специфичные в отношении tgf-бета 1
BRPI0613770A2 (pt)	2009-05-19	anticorpos anti-cd26 e métodos de uso destes
NO20082240L (no)	2008-07-22	GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
NO20055686L (no)	2007-06-04	Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
IL188611A0 (en)	2008-04-13	Sp1 polypeptides, modified sp1 polypeptides and uses thereof
DK1844072T3 (da)	2012-07-23	MHC-oligomer og fremgangsmåde til fremstilling deraf
WO2008154547A3 (en)	2009-02-26	Spider silk dragline polynucleotides, polypeptides and methods of use thereof
WO2008086035A3 (en)	2008-10-23	Split mutant hydrolase fusion reporter and uses thereof
MX2007011411A (es)	2007-11-13	Interaccion rage/diaphanous y composiciones relacionadas y metodos.
TW200711846A (en)	2007-04-01	Composite materials and methods of making the same
WO2007056760A3 (en)	2008-02-28	Hcv-reactive t cell receptors
ES1054865U (es)	2003-09-01	Junta vertical para bloque ceramico utilizado en fabrica armada mediante costillas
ITTR20050009U1 (it)	2006-12-17	Quaderno, quadernone, blocco o album con copertina personalizzata.
ITTR20050010U1 (it)	2006-12-17	Quaderno, quadernone, blocco o album con copertina personalizzata.
IL242077A0 (en)	2015-11-30	sp1 type polypeptides and the like, and their use
ES1053847Y (es)	2003-09-01	Perfeccionamientos introducidos en carteras.

Legal Events

Date	Code	Title	Description
2018-05-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application